Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare
Alaunos Therapeutics Inc. Shareholder Equity 2011–2025
Alaunos Therapeutics Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Alaunos Therapeutics Inc. shareholder equity as of December 31, 2025: 2.2M, a 4.36% increase year-over-year.
- Alaunos Therapeutics Inc. shareholder equity for 2025 were 2.2M, a 4.36% increase from 2024.
- Alaunos Therapeutics Inc. shareholder equity for 2024 were 2.1M, a 67.29% decrease from 2023.
- Alaunos Therapeutics Inc. shareholder equity for 2023 were 6.3M, a 83.64% decrease from 2022.
- Alaunos Therapeutics Inc. shareholder equity for 2022 were 38.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Alaunos Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $2 |
| 2024 | $2 |
| 2023 | $6 |
| 2022 | $39 |
| 2021 | $58 |
| 2020 | $124 |
| 2018 | $86 |
| 2017 | $-97 |
| 2016 | $-77 |
| 2012 | $48 |
| 2011 | $72 |
Alaunos Therapeutics Inc. Shareholder Equity — FAQ
Alaunos Therapeutics Inc. (TCRT) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRT's shareholder equity history?
The chart and table above show Alaunos Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.